The Microfluidic Immunoassay Market was valued at $0.92 billion in 2023 and is projected to grow to $1.59 billion by 2031, starting from an estimated $0.98 billion in 2024, with a CAGR of 7.3% over the forecast period from
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok